{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:56:32Z","timestamp":1789872992474,"version":"4.0.1"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jconrel.2020.10.035","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T01:10:19Z","timestamp":1603156219000},"page":"1066-1076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Drug delivery to optimize angiogenesis imbalance in keloid: A review"],"prefix":"10.1016","volume":"329","author":[{"given":"Aishwari.S.","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaladhar","family":"Kamalasanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.10.035_bb0005","series-title":"Dermatological Cryosurgery and Cryotherapy","first-page":"413","article-title":"Cryosurgical treatment of keloids and hypertrophic scars","author":"Zouboulis","year":"2016"},{"issue":"2","key":"10.1016\/j.jconrel.2020.10.035_bb0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.bbrc.2017.06.040","article-title":"miR-141-3p inhibits fibroblast proliferation and migration by targeting GAB1 in keloids","volume":"490","author":"Feng","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.matbio.2016.01.013","article-title":"Keloids: the paradigm of skin fibrosis\u2014Pathomechanisms and treatment","volume":"51","author":"Andrews","year":"2016","journal-title":"Matrix Biol."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s41038-019-0175-y","article-title":"Diagnosis and treatment of keloids and hypertrophic scars\u2014Japan scar workshop consensus document 2018","volume":"7","author":"Ogawa","year":"2019","journal-title":"Burns Trauma."},{"issue":"14","key":"10.1016\/j.jconrel.2020.10.035_bb0025","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.4103\/0366-6999.209896","article-title":"Radiation therapy in keloids treatment: history, strategy, effectiveness, and complication","volume":"130","author":"Xu","year":"2017","journal-title":"Chin. Med. J."},{"issue":"3","key":"10.1016\/j.jconrel.2020.10.035_bb0030","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/ijms18030606","article-title":"Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis","volume":"18","author":"Ogawa","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/0973-029X.110701","article-title":"Keloid: a case report and review of pathophysiology and differences between keloid and hypertrophic scars","volume":"17","author":"Hunasgi","year":"2013","journal-title":"J. Oral Maxillofac. Pathol. JOMFP."},{"issue":"4","key":"10.1016\/j.jconrel.2020.10.035_bb0040","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jamcollsurg.2007.12.001","article-title":"Current progress in keloid research and treatment","volume":"206","author":"Butler","year":"2008","journal-title":"J. Am. Coll. Surg."},{"issue":"4","key":"10.1016\/j.jconrel.2020.10.035_bb0045","article-title":"Keloids and hypertrophic scars: update and future directions","volume":"1","author":"Huang","year":"2013","journal-title":"Plast. Reconst. Surg. Global Open"},{"issue":"1\u20133","key":"10.1016\/j.jconrel.2020.10.035_bb0050","first-page":"1","article-title":"Novel insights on understanding of keloid scar: article review","volume":"7","author":"Mari","year":"2015","journal-title":"J. Am. Coll. Clin. Wound Special."},{"issue":"4","key":"10.1016\/j.jconrel.2020.10.035_bb0055","first-page":"243","article-title":"Role of angiogenesis and angiogenic factors in acute and chronic wound healing","volume":"2","author":"Honnegowda","year":"2015","journal-title":"Plast. Aesthet. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1087-0024.2000.00014.x","article-title":"Angiogenesis in wound healing","volume":"5","author":"Tonnesen","year":"2000","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"issue":"6","key":"10.1016\/j.jconrel.2020.10.035_bb0065","doi-asserted-by":"crossref","first-page":"A39","DOI":"10.1016\/j.jvs.2007.02.068","article-title":"Angiogenesis and vasculogenesis: Inducing the growth of new blood vessels and wound healing by stimulation of bone marrow\u2013derived progenitor cell mobilization and homing","volume":"45","author":"Velazquez","year":"2007","journal-title":"J. Vasc. Surg."},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0070","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/BCR.0b013e3181c7ed82","article-title":"Molecular mediators of angiogenesis","volume":"31","author":"Ucuzian","year":"2010","journal-title":"J. Burn Care Res."},{"issue":"10","key":"10.1016\/j.jconrel.2020.10.035_bb0075","first-page":"1675","article-title":"Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumors","volume":"7","author":"Dey","year":"2015","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2020.10.035_bb0080","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3892\/mmr.2014.2827","article-title":"Upregulated periostin promotes angiogenesis in keloids through activation of the ERK 1\/2 and focal adhesion kinase pathways, as well as the upregulated expression of VEGF and angiopoietin-1","volume":"11","author":"Zhang","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.jconrel.2020.10.035_bb0085","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4155\/tde.12.50","article-title":"Therapeutic angiogenesis: controlled delivery of angiogenic factors","volume":"3","author":"Chu","year":"2012","journal-title":"Ther. Deliv."},{"issue":"6","key":"10.1016\/j.jconrel.2020.10.035_bb0090","first-page":"1375","article-title":"Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair","volume":"140","author":"Pierce","year":"1992","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0095","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.prs.0000195073.73580.46","article-title":"Keloid pathogenesis and treatment","volume":"117","author":"Al-Attar","year":"2006","journal-title":"Plast. Reconstr. Surg."},{"issue":"4","key":"10.1016\/j.jconrel.2020.10.035_bb0100","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1365-2133.2006.07714.x","article-title":"Application of topical mitomycin C to the base of shave-removed keloid scars to prevent their recurrence","volume":"156","author":"Bailey","year":"2007","journal-title":"Br. J. Dermatol."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2020.10.035_bb0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2119\/molmed.2009.00153","article-title":"Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies","volume":"17","author":"Gauglitz","year":"2011","journal-title":"Mol. Med."},{"issue":"7193","key":"10.1016\/j.jconrel.2020.10.035_bb0110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature"},{"issue":"265","key":"10.1016\/j.jconrel.2020.10.035_bb0115","doi-asserted-by":"crossref","first-page":"265sr6","DOI":"10.1126\/scitranslmed.3009337","article-title":"Wound repair and regeneration: mechanisms, signaling, and translation","volume":"6","author":"Eming","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2020.10.035_bb0120","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1365-2133.2006.07714.x","article-title":"Application of topical mitomycin C to the base of shave-removed keloid scars to prevent their recurrence","volume":"156","author":"Bailey","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0125","first-page":"67","article-title":"New approach to the understanding of keloid: psychoneuroimmune\u2013endocrine aspects","volume":"8","author":"Hochman","year":"2015","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0130","first-page":"105","article-title":"Morphological and immunochemical differences between keloid and hypertrophic scar","volume":"145","author":"Ehrlich","year":"1994","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.jconrel.2020.10.035_bb0135","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0190-9622(85)70213-7","article-title":"Cutaneous tissue repair: basic biologic considerations. I","volume":"13","author":"Clark","year":"1985","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0140","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1524-475X.2006.00193.x","article-title":"Prostaglandin E2 inhibition of keloid fibroblast migration, contraction, and transforming growth factor (TGF)-\u03b21\u2013induced collagen synthesis","volume":"15","author":"Sandulache","year":"2007","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jemt.10249","article-title":"Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix","volume":"60","author":"Li","year":"2003","journal-title":"Microsc. Res. Tech."},{"issue":"5","key":"10.1016\/j.jconrel.2020.10.035_bb0150","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1189\/jlb.4MR0316-102R","article-title":"Angiogenesis and wound repair: when enough is enough","volume":"100","author":"DiPietro","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0155","doi-asserted-by":"crossref","first-page":"8173983","DOI":"10.1155\/2018\/8173983","article-title":"Neutrophils in tissue trauma of the skin, bone, and lung: two sides of the same coin","volume":"2018","author":"Kovtun","year":"2018","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.jconrel.2020.10.035_bb0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.proghi.2007.06.001","article-title":"Regulation of angiogenesis: wound healing as a model","volume":"42","author":"Eming","year":"2007","journal-title":"Prog. Histochem. Cytochem."},{"issue":"3","key":"10.1016\/j.jconrel.2020.10.035_bb0165","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0163-7258(91)90034-J","article-title":"Angiogenesis in wound healing","volume":"52","author":"Arnold","year":"1991","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/wound.2011.0308","article-title":"Wound healing angiogenesis: innovations and challenges in acute and chronic wound healing","volume":"1","author":"Demidova-Rice","year":"2012","journal-title":"Adv. Wound Care."},{"issue":"9","key":"10.1016\/j.jconrel.2020.10.035_bb0175","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.tcb.2010.06.006","article-title":"Signaling by members of the TGF-\u03b2 family in vascular morphogenesis and disease","volume":"20","author":"Pardali","year":"2010","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.jconrel.2020.10.035_bb0180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1160\/TH06-08-0470","article-title":"Signal transduction induced in endothelial cells by growth factor receptors involved in angiogenesis","volume":"97","author":"Hofer","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.jconrel.2020.10.035_bb0185","doi-asserted-by":"crossref","first-page":"a005058","DOI":"10.1101\/cshperspect.a005058","article-title":"Extracellular matrix degradation and remodeling in development and disease","volume":"3","author":"Lu","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0190","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1590\/abd1806-4841.20164741","article-title":"Wound healing-a literature review*","volume":"91","author":"Cristina","year":"2016","journal-title":"An. Bras. Dermatol."},{"issue":"3","key":"10.1016\/j.jconrel.2020.10.035_bb0195","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.trsl.2011.10.002","article-title":"Altered angiogenic balance in keloids: a key to therapeutic intervention","volume":"159","author":"Mogili","year":"2012","journal-title":"Transl. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2020.10.035_bb0200","first-page":"1445","article-title":"Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing","volume":"152","author":"Nissen","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0205","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jconrel.2015.02.013","article-title":"Epicardial delivery of VEGF and cardiac stem cells guided by 3-dimensional PLLA mat enhancing cardiac regeneration and angiogenesis in acute myocardial infarction","volume":"205","author":"Chung","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2017.02.009","article-title":"Perlecan and vascular endothelial growth factor-encoding DNA-loaded chitosan scaffolds promote angiogenesis and wound healing","volume":"250","author":"Lord","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0215","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/CCID.S133672","article-title":"Triamcinolone acetonide intralesional injection for the treatment of keloid scars: patient selection and perspectives","volume":"11","author":"Morelli Coppola","year":"2018","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"issue":"6","key":"10.1016\/j.jconrel.2020.10.035_bb0220","doi-asserted-by":"crossref","first-page":"620","DOI":"10.5999\/aps.2014.41.6.620","article-title":"Recent developments in the use of intralesional injections keloid treatment","volume":"41","author":"Trisliana Perdanasari","year":"2014","journal-title":"Arch. Plast. Surg."},{"issue":"4","key":"10.1016\/j.jconrel.2020.10.035_bb0225","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/archsurg.1991.01410280103016","article-title":"Topical silicone gel for the prevention and treatment of hypertrophic scar","volume":"126","author":"Ahn","year":"1991","journal-title":"Arch. Surg."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0230","series-title":"StatPearls [Internet]","article-title":"Radiation therapy in the treatment of keloids. 2020 Aug 15","author":"Zainib","year":"2020"},{"issue":"7","key":"10.1016\/j.jconrel.2020.10.035_bb0235","first-page":"23","article-title":"Use of intralesional cryosurgery as an innovative therapy for keloid scars and a review of current treatments","volume":"6","author":"Goldenberg","year":"2013","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0240","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.matbio.2016.01.013","article-title":"Keloids: the paradigm of skin fibrosis\u2014Pathomechanisms and treatment","volume":"51","author":"Andrews","year":"2016","journal-title":"Matrix Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2020.10.035_bb0245","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/DSS.0000000000000819","article-title":"Keloids and hypertrophic scars: pathophysiology, classification, and treatment","volume":"43","author":"Berman","year":"2017","journal-title":"Dermatol. Surg."},{"issue":"2","key":"10.1016\/j.jconrel.2020.10.035_bb0250","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s13555-019-0298-x","article-title":"The scar bane, without the pain: a new approach in the treatment of elevated scars: thermomechanical delivery of topical triamcinolone acetonide and 5-fluorouracil","volume":"9","author":"Artzi","year":"2019","journal-title":"Dermatol. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0255","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijrobp.2008.12.066","article-title":"Dose\u2013effect relationships for recurrence of keloid and pterygium after surgery and radiotherapy","volume":"74","author":"Kal","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.jconrel.2020.10.035_bb0260","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00266-006-0253-y","article-title":"Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods","volume":"31","author":"Atiyeh","year":"2007","journal-title":"Aesthet. Plast. Surg."},{"issue":"3","key":"10.1016\/j.jconrel.2020.10.035_bb0265","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/0974-2077.101376","article-title":"Cryotherapy in treatment of keloids: evaluation of factors affecting treatment outcome","volume":"5","author":"Barara","year":"2012","journal-title":"J Cutan Aesthet Surg"},{"issue":"2","key":"10.1016\/j.jconrel.2020.10.035_bb0270","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s13555-016-0118-5","article-title":"5-Fluorouracil in the treatment of keloids and hypertrophic scars: a comprehensive review of the literature","volume":"6","author":"Shah","year":"2016","journal-title":"Dermatol. Ther. (Heidelb)."},{"issue":"9","key":"10.1016\/j.jconrel.2020.10.035_bb0275","article-title":"5-Fluorouracil for keloid scars","volume":"2017","author":"Rabey","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2020.10.035_bb0280","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/0974-2077.58527","article-title":"The efficacy of silicone gel for the treatment of hypertrophic scars and keloids","volume":"2","author":"Puri","year":"2009","journal-title":"J Cutan Aesthet Surg"},{"issue":"8","key":"10.1016\/j.jconrel.2020.10.035_bb0285","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/2141-9248.138040","article-title":"Custom made pressure appliance for presurgical sustained compression of auricular keloid","volume":"4","author":"Rathee","year":"2014","journal-title":"Ann. Med. Health Sci. Res."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0290","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2020.10.035_bb0295","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.burns.2014.02.011","article-title":"Up-to-date approach to manage keloids and hypertrophic scars: a useful guide","volume":"40","author":"Arno","year":"2014","journal-title":"Burns."},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0300","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cdtm.2017.01.002","article-title":"Revision of the concept of anti-angiogenesis and its applications in tumor treatment","volume":"3","author":"Yang","year":"2017","journal-title":"Chronic Diseas. Transl. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2020.10.035_bb0305","doi-asserted-by":"crossref","DOI":"10.3171\/2015.5.FOCUS15143","article-title":"The genetic basis of intradural spinal tumors and its impact on clinical treatment","volume":"39","author":"Karsy","year":"2015","journal-title":"Neurosurg. Focus."},{"issue":"36","key":"10.1016\/j.jconrel.2020.10.035_bb0310","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.1073\/pnas.0405220101","article-title":"EGF receptor gene mutations are common in lung cancers from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib","volume":"101","author":"Pao","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2020.10.035_bb0315","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1634\/theoncologist.8-4-303","article-title":"FDA drug approval summary: gefitinib (ZD1839)(Iressa\u00ae) tablets","volume":"8","author":"Cohen","year":"2003","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.jconrel.2020.10.035_bb0320","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrd2332","article-title":"Lapatinib","volume":"6","author":"Moy","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"25","key":"10.1016\/j.jconrel.2020.10.035_bb0325","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1200\/JCO.2007.11.1336","article-title":"Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non\u2013small-cell lung cancer","volume":"25","author":"J\u00e4nne","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.jconrel.2020.10.035_bb0330","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1634\/theoncologist.12-4-443","article-title":"Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer","volume":"12","author":"Los","year":"2007","journal-title":"Oncologist."},{"issue":"4","key":"10.1016\/j.jconrel.2020.10.035_bb0335","first-page":"1323","article-title":"A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma","volume":"9","author":"Posey","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0340","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnci\/dji003","article-title":"Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody","volume":"97","author":"Pytowski","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0345","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S1470-2045(01)00608-8","article-title":"FDA licences imatinib mesylate for CML","volume":"3","author":"Habeck","year":"2002","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.jconrel.2020.10.035_bb0350","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1158\/1078-0432.CCR-06-2328","article-title":"Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma","volume":"13","author":"Goodman","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.jconrel.2020.10.035_bb0355","first-page":"379","article-title":"FDA approves sorafenib for patients with inoperable liver cancer","volume":"134","author":"Lang","year":"2008","journal-title":"Gastroenterology."},{"issue":"2","key":"10.1016\/j.jconrel.2020.10.035_bb0360","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jcb.21296","article-title":"Effects of Vitaxin\u00ae, a novel therapeutic in trial for metastatic bone tumors, on osteoclast functions in vitro","volume":"102","author":"Gramoun","year":"2007","journal-title":"J. Cell. Biochem."},{"issue":"14 Pt 2","key":"10.1016\/j.jconrel.2020.10.035_bb0365","doi-asserted-by":"crossref","first-page":"4421s","DOI":"10.1158\/1078-0432.CCR-06-0796","article-title":"Combining targeted agents: blocking the epidermal growth factor and vascular endothelial growth factor pathways","volume":"12","author":"Sandler","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0370","first-page":"12(3)","article-title":"FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer","volume":"1","author":"Cohen","year":"2007","journal-title":"Oncologist."},{"issue":"2","key":"10.1016\/j.jconrel.2020.10.035_bb0375","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1517\/13543784.17.2.253","article-title":"Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma","volume":"17","author":"Sonpavde","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"2","key":"10.1016\/j.jconrel.2020.10.035_bb0380","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/wound.2018.0828","article-title":"Animal models for studies of keloid scarring","volume":"8","author":"Supp","year":"2019","journal-title":"Adv. Wound Care"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0385","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.matbio.2016.01.014","article-title":"Keloids: animal models and pathologic equivalents to study tissue fibrosis","volume":"51","author":"Marttala","year":"2016","journal-title":"Matrix Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0390","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1101\/pdb.top069757","article-title":"Of model pets and cancer models: an introduction to mouse models of cancer","volume":"2014","author":"Lunardi","year":"2014","journal-title":"Cold Spring Harb Protoc"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0395","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2147\/DDDT.S49584","article-title":"Animal models and therapeutic molecular targets of cancer: utility and limitations","volume":"8","author":"Cekanova","year":"2014","journal-title":"Drug Design Develop. Ther."},{"issue":"3","key":"10.1016\/j.jconrel.2020.10.035_bb0400","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.eururo.2010.05.024","article-title":"Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer","volume":"58","author":"Wang","year":"2010","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0405","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/1471-2407-13-403","article-title":"Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype","volume":"13","author":"Wiese","year":"2013","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.jconrel.2020.10.035_bb0410","first-page":"80","article-title":"Platelet-rich plasma gel promotes regeneration of articular cartilage in knees of sheeps","volume":"21","author":"de Oliveira","year":"2013","journal-title":"Acta Ortoped. Brasil."},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0415","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jbm.b.31928","article-title":"Tissue engineering of small-diameter vascular grafts by endothelial progenitor cells seeding heparin-coated decellularized scaffolds","volume":"100","author":"Zhou","year":"2012","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"issue":"5","key":"10.1016\/j.jconrel.2020.10.035_bb0420","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.copbio.2013.05.005","article-title":"Animal models for vascular tissue-engineering","volume":"24","author":"Swartz","year":"2013","journal-title":"Curr. Opin. Biotechnol."},{"issue":"4","key":"10.1016\/j.jconrel.2020.10.035_bb0425","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s13770-018-0129-7","article-title":"Mesenchymal stem cells of different origin-seeded bioceramic construct in regeneration of bone defect in rabbit","volume":"15","author":"Maiti","year":"2018","journal-title":"Tissue Eng. Regen. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2020.10.035_bb0430","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2007.09.013","article-title":"Nano\/micro technologies for delivering macromolecular therapeutics using poly (D, L-lactide-co-glycolide) and its derivatives","volume":"125","author":"Mundargi","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0435","doi-asserted-by":"crossref","first-page":"101525","DOI":"10.1016\/j.jddst.2020.101525","article-title":"Tailor-made electrically-responsive poly (acrylamide)-graft-pullulan copolymer based transdermal drug delivery systems: synthesis, characterization, in-vitro and ex-vivo evaluation","volume":"56","author":"Patil","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0440","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jbm.a.30710","article-title":"Cell mimetic monolayer supported chitosan-haemocompatibility studies","volume":"79","author":"Mathews","year":"2006","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0445","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12951-019-0514-y","article-title":"Nano-drug delivery systems in wound treatment and skin regeneration","volume":"17","author":"Wang","year":"2019","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0450","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.colsurfb.2014.07.006","article-title":"Supramolecularcurcumin\u2013barium prodrugs for formulating with ceramic particles","volume":"122","author":"Kamalasanan","year":"2014","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"6","key":"10.1016\/j.jconrel.2020.10.035_bb0455","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.nano.2015.03.002","article-title":"Advances in drug delivery systems (DDSs) to release growth factors for wound healing and skin regeneration","volume":"11","author":"Gainza","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0460","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.addr.2018.03.012","article-title":"Instructive microenvironments in skin wound healing: biomaterials as signal releasing platforms","volume":"129","author":"Castano","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0465","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.msec.2016.05.074","article-title":"Recent advancements in nanotechnological strategies in selection, design and delivery of biomolecules for skin regeneration","volume":"67","author":"Korrapati","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0470","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2015.10.049","article-title":"Nanoparticles and nanofibers for topical drug delivery","volume":"240","author":"Goyal","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0475","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.mimet.2019.03.009","article-title":"Novel biocompatible poly (acrylamide)-grafted-dextran hydrogels: Synthesis, characterization and biomedical applications","volume":"159","author":"Patil","year":"2019","journal-title":"J. Microbiol. Methods"},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0480","first-page":"35","article-title":"Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer\u2019s disease","volume":"2","author":"Kulkarni","year":"2010","journal-title":"Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0485","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4172\/2155-952X.1000276","article-title":"Liposomes for drug delivery","volume":"7","author":"Yadav","year":"2017","journal-title":"J. Biotechnol. Biomater."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0490","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0495","series-title":"Drug Delivery Nanosystems for Biomedical Applications","first-page":"45","article-title":"Pharmaceutical perspectives of selection criteria and toxicity profiling of nanotheranostic agents","volume":"Chapter 4","author":"Radhakrishnan","year":"2018"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0500","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2020.06.019","article-title":"Controlled drug delivery for alopecia: a review","volume":"325","author":"Shefrin","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0505","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jconrel.2017.06.001","article-title":"Nanomedicine for prostate cancer using nanoemulsion: a review","volume":"260","author":"Sasikumar","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0510","series-title":"AIP Conference Proceedings","doi-asserted-by":"crossref","first-page":"020048","DOI":"10.1063\/1.4945168","article-title":"Green synthesis of nanoparticles: their advantages and disadvantages","volume":"1724(1)","author":"Parveen","year":"2016"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0515","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00079","article-title":"Nanoscale drug delivery systems: from medicine to agriculture","volume":"8","author":"Vega-V\u00e1squez","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"8","key":"10.1016\/j.jconrel.2020.10.035_bb0520","first-page":"95","article-title":"An overview of nanogel drug delivery system","volume":"3","author":"Sultana","year":"2013","journal-title":"J. Appl. Pharm. Sci."},{"issue":"48","key":"10.1016\/j.jconrel.2020.10.035_bb0525","doi-asserted-by":"crossref","first-page":"25576","DOI":"10.1039\/c3ra45414b","article-title":"Electrospun lithium metal oxide cathode materials for lithium-ion batteries","volume":"3","author":"Kalluri","year":"2013","journal-title":"RSC Adv."},{"issue":"19","key":"10.1016\/j.jconrel.2020.10.035_bb0530","doi-asserted-by":"crossref","first-page":"1700344","DOI":"10.1002\/adhm.201700344","article-title":"Liposomes with silk fibroin hydrogel core to stabilize bfgf and promote the wound healing of mice with deep second-degree scald","volume":"6","author":"Xu","year":"2017","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0535","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.2147\/IJN.S105035","article-title":"Increased cutaneous wound healing effect of biodegradable liposomes containing madecassoside: preparation optimization, in vitro dermal permeation, and in vivo bioevaluation","volume":"11","author":"Li","year":"2016","journal-title":"Int. J. Nanomedicine"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2020.10.035_bb0540","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijpharm.2016.09.040","article-title":"Gelatin-based membrane containing usnic acid-loaded liposome improves dermal burn healing in a porcine model","volume":"513","author":"Nunes","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0545","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.actbio.2017.04.034","article-title":"Preparation and in vivo evaluation of cationic elastic liposomes comprising highly skin-permeable growth factors combined with hyaluronic acid for enhanced diabetic wound-healing therapy","volume":"57","author":"Choi","year":"2017","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.jconrel.2020.10.035_bb0550","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s13346-017-0405-4","article-title":"Evaluation of propylene glycol nanoliposomes containing curcumin on burn wound model in rat: biocompatibility, wound healing, and anti-bacterial effects","volume":"7","author":"Kianvash","year":"2017","journal-title":"Drug Deliv. Transl. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2020.10.035_bb0555","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.nano.2017.12.001","article-title":"Nanodesign of new self-assembling core-shell gellan-transfersomes loading baicalin and in vivo evaluation of repair response in skin","volume":"14","author":"Manconi","year":"2018","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0560","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/cmdc.200600171","article-title":"Topical delivery of silver nanoparticles promotes wound healing","volume":"2","author":"Tian","year":"2007","journal-title":"ChemMedChem."},{"issue":"9","key":"10.1016\/j.jconrel.2020.10.035_bb0565","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.biomaterials.2012.11.061","article-title":"Effects of cerium oxide nanoparticles on the growth of keratinocytes, fibroblasts and vascular endothelial cells in cutaneous wound healing","volume":"34","author":"Chigurupati","year":"2013","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0570","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.2147\/IJN.S141201","article-title":"Synthesized zinc peroxide nanoparticles (ZnO2-NPs): a novel antimicrobial, anti-elastase, anti-keratinase, and anti-inflammatory approach toward polymicrobial burn wounds","volume":"12","author":"Ali","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0575","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2014.08.016","article-title":"PLGA nanoparticles loaded with host defense peptide LL37 promote wound healing","volume":"194","author":"Chereddy","year":"2014","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2020.10.035_bb0580","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/02652048.2017.1337249","article-title":"Hybrid nanoparticles for the topical delivery of norfloxacin for the effective treatment of bacterial infection produced after burn","volume":"34","author":"Dave","year":"2017","journal-title":"J. Microencapsul."},{"issue":"1","key":"10.1016\/j.jconrel.2020.10.035_bb0585","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.nano.2013.06.002","article-title":"Amphotericin B releasing nanoparticle topical treatment of Candida spp. in the setting of a burn wound","volume":"10","author":"Sanchez","year":"2014","journal-title":"Nanomedicine"},{"issue":"8","key":"10.1016\/j.jconrel.2020.10.035_bb0590","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1073\/pnas.0905432106","article-title":"Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0595","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.msec.2018.03.034","article-title":"Evaluation of nano hydrogel composite based on gelatin\/HA\/CS suffused with Asiatic acid\/ZnO and CuO nanoparticles for second degree burns","volume":"89","author":"Thanusha","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0600","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.carbpol.2017.11.109","article-title":"Injectable methylcellulose hydrogel containing silver oxide nanoparticles for burn wound healing","volume":"181","author":"Kim","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0605","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejps.2013.10.006","article-title":"Sol\u2013gel processed mupirocin silica microspheres loaded collagen scaffold: a synergistic bio-composite for wound healing","volume":"52","author":"Perumal","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0610","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2014.04.032","article-title":"A novel strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded lipid nanoparticles: In vitro bioactivity and in vivo effectiveness in healing-impaired db\/db mice","volume":"185","author":"Gainza","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0615","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.carbpol.2017.05.098","article-title":"Chitosan\u2013hyaluronic acid composite sponge scaffold enriched with andrographolide-loaded lipid nanoparticles for enhanced wound healing","volume":"173","author":"Sanad","year":"2017","journal-title":"Carbohydr. Polym."},{"issue":"7","key":"10.1016\/j.jconrel.2020.10.035_bb0620","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1021\/acs.molpharmaceut.6b00099","article-title":"Nanoparticles encapsulated with LL37 and serpin A1 promotes wound healing and synergistically enhances antibacterial activity","volume":"13","author":"Fumakia","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0625","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.2147\/IJN.S36883","article-title":"A new approach to the treatment of recurrent aphthous stomatitis with bioadhesive gels containing cyclosporine A solid lipid nanoparticles: in vivo\/in vitro examinations","volume":"7","author":"Karavana","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0630","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ijbiomac.2018.11.237","article-title":"Controlled release of lawsone from polycaprolactone\/gelatin electrospun nano fibers for skin tissue regeneration","volume":"124","author":"Adeli-Sardou","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.jconrel.2020.10.035_bb0635","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijpharm.2014.12.067","article-title":"Silk fibroin\/gelatin electrospun nanofibrous dressing functionalized with astragaloside IV induces healing and anti-scar effects on burn wound","volume":"479","author":"Shan","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0640","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijbiomac.2016.05.094","article-title":"Nano-TiO2\/collagen-chitosan porous scaffold for wound repairing","volume":"91","author":"Fan","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"issue":"9","key":"10.1016\/j.jconrel.2020.10.035_bb0645","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1021\/acsnano.7b03513","article-title":"Photo-inspired antibacterial activity and wound healing acceleration by hydrogel embedded with Ag\/Ag@ AgCl\/ZnO nanostructures","volume":"11","author":"Mao","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0650","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.actbio.2018.01.045","article-title":"Nanoengineered injectable hydrogels for wound healing application","volume":"70","author":"Lokhande","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2020.10.035_bb0655","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.biomaterials.2018.01.033","article-title":"Nanofibrous peptide hydrogel elicits angiogenesis and neurogenesis without drugs, proteins, or cells","volume":"161","author":"Moore","year":"2018","journal-title":"Biomaterials."},{"issue":"46","key":"10.1016\/j.jconrel.2020.10.035_bb0660","doi-asserted-by":"crossref","first-page":"39532","DOI":"10.1021\/acsami.8b16645","article-title":"Cellular and molecular interaction of human dermal fibroblasts with bacterial nanocellulose composite hydrogel for tissue regeneration","volume":"10","author":"Xi Loh","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2020.10.035_bb0665","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejpb.2018.02.015","article-title":"Preparation of gellan-cholesterol nanohydrogels embedding baicalin and evaluation of their wound healing activity","volume":"127","author":"Manconi","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"17","key":"10.1016\/j.jconrel.2020.10.035_bb0670","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1016\/j.biomaterials.2014.02.047","article-title":"Ultrashort peptide nanofibrous hydrogels for the acceleration of healing of burn wounds","volume":"35","author":"Loo","year":"2014","journal-title":"Biomaterials."},{"issue":"5","key":"10.1016\/j.jconrel.2020.10.035_bb0675","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1089\/hgtb.2012.032","article-title":"Controlled angiogenesis in the heart by cell-based expression of specific vascular endothelial growth factor levels","volume":"23","author":"Melly","year":"2012","journal-title":"Human Gene Therapy, Part B: Methods."},{"issue":"4","key":"10.1016\/j.jconrel.2020.10.035_bb0680","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1517\/17425247.2011.558082","article-title":"Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis","volume":"8","author":"Bhise","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"issue":"30","key":"10.1016\/j.jconrel.2020.10.035_bb0685","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1016\/j.biomaterials.2010.07.010","article-title":"Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis","volume":"31","author":"Tengood","year":"2010","journal-title":"Biomaterials."},{"issue":"9\u201310","key":"10.1016\/j.jconrel.2020.10.035_bb0690","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1089\/ten.tea.2010.0551","article-title":"Sequential delivery of basic fibroblast growth factor and platelet-derived growth factor for angiogenesis","volume":"17","author":"Tengood","year":"2011","journal-title":"Tissue Eng. A"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920306131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920306131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:14:59Z","timestamp":1759162499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920306131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":138,"alternative-id":["S0168365920306131"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.10.035","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug delivery to optimize angiogenesis imbalance in keloid: A review","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.10.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}